Erratum to: Per-capita consumption of analgesics: a nine-country survey over 20 years
© Springer-Verlag 2008
Published: 20 August 2008
The original article was published in The Journal of Headache and Pain 2008 9:46
Erratum to: J Headache Pain DOI 10.1007/s10194-008-0046-6
This article unfortunately contained errors in two places.
Relative proportions of standardised medication units (SU) among different countries comparing weighted and unweighted proportions
Relative proportions of ASA consumption
Weighted by mg ASA (%)
Total 9 countries
2. Incorrect percentages were given in the last paragraph of the “Results” section, immediately before the “Discussion”. The corrected paragraph is as follows:
In 2005 in the prescription (Rx) group of N2B analgesics, combination products accounted for approx. 33% of all Rx analgesics in terms of SU. The most important combinations are tilidine plus naloxone (14% of all SU in the Rx group), followed by codeine plus paracetamol (12%). The predominating single products in the Rx group are metamizole (36%) and tramadol (21%). Growth in the Rx group can be seen for both the combinations named and the single products.